Copyright Reports & Markets. All rights reserved.

Global Companion Animal Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Companion Animal Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Antibiotics and Antimicrobials
      • 1.4.3 Parasiticides
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Companion Animal Drugs Market Share by Application (2014-2025)
      • 1.5.2 Dogs
      • 1.5.3 Cats
      • 1.5.4 Horses
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Companion Animal Drugs Market Size
    • 2.2 Companion Animal Drugs Growth Trends by Regions
      • 2.2.1 Companion Animal Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Companion Animal Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Companion Animal Drugs Market Size by Manufacturers
      • 3.1.1 Global Companion Animal Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Companion Animal Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Companion Animal Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Companion Animal Drugs Key Players Head office and Area Served
    • 3.3 Key Players Companion Animal Drugs Product/Solution/Service
    • 3.4 Date of Enter into Companion Animal Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Companion Animal Drugs Market Size by Type (2014-2019)
    • 4.2 Global Companion Animal Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Companion Animal Drugs Market Size (2014-2019)
    • 5.2 Companion Animal Drugs Key Players in United States
    • 5.3 United States Companion Animal Drugs Market Size by Type
    • 5.4 United States Companion Animal Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Companion Animal Drugs Market Size (2014-2019)
    • 6.2 Companion Animal Drugs Key Players in Europe
    • 6.3 Europe Companion Animal Drugs Market Size by Type
    • 6.4 Europe Companion Animal Drugs Market Size by Application

    7 China

    • 7.1 China Companion Animal Drugs Market Size (2014-2019)
    • 7.2 Companion Animal Drugs Key Players in China
    • 7.3 China Companion Animal Drugs Market Size by Type
    • 7.4 China Companion Animal Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Companion Animal Drugs Market Size (2014-2019)
    • 8.2 Companion Animal Drugs Key Players in Japan
    • 8.3 Japan Companion Animal Drugs Market Size by Type
    • 8.4 Japan Companion Animal Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Companion Animal Drugs Market Size (2014-2019)
    • 9.2 Companion Animal Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Companion Animal Drugs Market Size by Type
    • 9.4 Southeast Asia Companion Animal Drugs Market Size by Application

    10 India

    • 10.1 India Companion Animal Drugs Market Size (2014-2019)
    • 10.2 Companion Animal Drugs Key Players in India
    • 10.3 India Companion Animal Drugs Market Size by Type
    • 10.4 India Companion Animal Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Companion Animal Drugs Market Size (2014-2019)
    • 11.2 Companion Animal Drugs Key Players in Central & South America
    • 11.3 Central & South America Companion Animal Drugs Market Size by Type
    • 11.4 Central & South America Companion Animal Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Zoetis
      • 12.1.1 Zoetis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Companion Animal Drugs Introduction
      • 12.1.4 Zoetis Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.1.5 Zoetis Recent Development
    • 12.2 Bayer
      • 12.2.1 Bayer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Companion Animal Drugs Introduction
      • 12.2.4 Bayer Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.2.5 Bayer Recent Development
    • 12.3 Boehringer Ingelheim
      • 12.3.1 Boehringer Ingelheim Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Companion Animal Drugs Introduction
      • 12.3.4 Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.3.5 Boehringer Ingelheim Recent Development
    • 12.4 Eli Lilly
      • 12.4.1 Eli Lilly Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Companion Animal Drugs Introduction
      • 12.4.4 Eli Lilly Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.4.5 Eli Lilly Recent Development
    • 12.5 Merck
      • 12.5.1 Merck Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Companion Animal Drugs Introduction
      • 12.5.4 Merck Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.5.5 Merck Recent Development
    • 12.6 Vetoquinol
      • 12.6.1 Vetoquinol Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Companion Animal Drugs Introduction
      • 12.6.4 Vetoquinol Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.6.5 Vetoquinol Recent Development
    • 12.7 Virbac
      • 12.7.1 Virbac Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Companion Animal Drugs Introduction
      • 12.7.4 Virbac Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.7.5 Virbac Recent Development
    • 12.8 Dechra Pharmaceuticals
      • 12.8.1 Dechra Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Companion Animal Drugs Introduction
      • 12.8.4 Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.8.5 Dechra Pharmaceuticals Recent Development
    • 12.9 Ceva Sante Animale
      • 12.9.1 Ceva Sante Animale Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Companion Animal Drugs Introduction
      • 12.9.4 Ceva Sante Animale Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.9.5 Ceva Sante Animale Recent Development
    • 12.10 Aratana Therapeutics
      • 12.10.1 Aratana Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Companion Animal Drugs Introduction
      • 12.10.4 Aratana Therapeutics Revenue in Companion Animal Drugs Business (2014-2019)
      • 12.10.5 Aratana Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Companion Animal Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Companion Animal Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Animal Drugs development in United States, Europe and China.

      The key players covered in this study
      Zoetis
      Bayer
      Boehringer Ingelheim
      Eli Lilly
      Merck
      Vetoquinol
      Virbac
      Dechra Pharmaceuticals
      Ceva Sante Animale
      Aratana Therapeutics

      Market segment by Type, the product can be split into
      Antibiotics and Antimicrobials
      Parasiticides
      Others

      Market segment by Application, split into
      Dogs
      Cats
      Horses
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Companion Animal Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Companion Animal Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Companion Animal Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now